Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Oliva

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Implementation Science Communications|February 6, 2026
Constructing the program theory: an implementation science approach to understanding a successful interdisciplinary team-based model of rheumatology careLauren K King, Daphne To, Zeenat Ladak, et al.
Theranostics|January 22, 2024
Deep learning for automatic organ and tumor segmentation in nanomedicine pharmacokineticsAlex Dhaliwal, Jun Ma, Mark Zheng, et al.
International Journal of Computer Assisted Radiology and Surgery|April 9, 2023
A robotic system for solo surgery in flexible ureteroscopy: development and evaluation with clinical usersChristopher Schlenk, Katharina Hagmann, Florian Steidle, et al.
Neuropsychologia|May 24, 2020
Classification of general and personal semantic details in the Autobiographical InterviewLouis Renoult, Michael J Armson, Nicholas B Diamond, et al.
Nature Immunology|January 29, 2013
Plasma cells require autophagy for sustainable immunoglobulin productionNiccolò Pengo, Maria Scolari, Laura Oliva, et al.
Blood|January 24, 2009
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibitionGiada Bianchi, Laura Oliva, Paolo Cascio, et al.
The EMBO Journal|February 25, 2006
Progressively impaired proteasomal capacity during terminal plasma cell differentiationSimone Cenci, Alexandre Mezghrani, Paolo Cascio, et al.
Blood|January 29, 2017
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicityLaura Oliva, Ugo Orfanelli, Massimo Resnati, et al.
The Journal of Rheumatology|October 1, 2025
Evaluating Implementation Context to Prepare for Scaling Up the Integration of Interdisciplinary Healthcare Providers in Rheumatology Practices: A Rheumatology Workforce SurveyJessica Widdifield, Celia Laur, Timothy S H Kwok, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2013
MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunityElisa Benasciutti, Elisabetta Mariani, Laura Oliva, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Implementation Science Communications|February 6, 2026
Constructing the program theory: an implementation science approach to understanding a successful interdisciplinary team-based model of rheumatology careLauren K King, Daphne To, Zeenat Ladak, et al.
Theranostics|January 22, 2024
Deep learning for automatic organ and tumor segmentation in nanomedicine pharmacokineticsAlex Dhaliwal, Jun Ma, Mark Zheng, et al.
International Journal of Computer Assisted Radiology and Surgery|April 9, 2023
A robotic system for solo surgery in flexible ureteroscopy: development and evaluation with clinical usersChristopher Schlenk, Katharina Hagmann, Florian Steidle, et al.
Neuropsychologia|May 24, 2020
Classification of general and personal semantic details in the Autobiographical InterviewLouis Renoult, Michael J Armson, Nicholas B Diamond, et al.
Nature Immunology|January 29, 2013
Plasma cells require autophagy for sustainable immunoglobulin productionNiccolò Pengo, Maria Scolari, Laura Oliva, et al.
Blood|January 24, 2009
The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibitionGiada Bianchi, Laura Oliva, Paolo Cascio, et al.
The EMBO Journal|February 25, 2006
Progressively impaired proteasomal capacity during terminal plasma cell differentiationSimone Cenci, Alexandre Mezghrani, Paolo Cascio, et al.
Blood|January 29, 2017
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicityLaura Oliva, Ugo Orfanelli, Massimo Resnati, et al.
The Journal of Rheumatology|October 1, 2025
Evaluating Implementation Context to Prepare for Scaling Up the Integration of Interdisciplinary Healthcare Providers in Rheumatology Practices: A Rheumatology Workforce SurveyJessica Widdifield, Celia Laur, Timothy S H Kwok, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 17, 2013
MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunityElisa Benasciutti, Elisabetta Mariani, Laura Oliva, et al.
Pageof 5